YTHDF2 and melanoma: Remarkably, inhibition of FTO in melanoma has been found to suppress tumorigenicity and to increase the m6A levels in PD-1, CXCR1, and SOX10, hence enhancing the decay of these m6A-targeted mRNAs by YTHDF2.